Your browser doesn't support javascript.
loading
Determination of age-dependent bone marrow normocellularity.
Wong, Jerry; Jackson, Ryan; Chen, Lu; Song, Joo; Pillai, Raju; Afkhami, Michelle; Danilova, Olga; Aoun, Patricia; Gaal, Karl K; Kim, Young.
Afiliação
  • Wong J; Department of Pathology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, US.
  • Jackson R; Department of Pathology City of Hope National Medical Center, Duarte, CA, US.
  • Chen L; Department of Pathology City of Hope National Medical Center, Duarte, CA, US.
  • Song J; Department of Pathology City of Hope National Medical Center, Duarte, CA, US.
  • Pillai R; Department of Pathology City of Hope National Medical Center, Duarte, CA, US.
  • Afkhami M; Department of Pathology City of Hope National Medical Center, Duarte, CA, US.
  • Danilova O; Department of Pathology City of Hope National Medical Center, Duarte, CA, US.
  • Aoun P; Department of Pathology City of Hope National Medical Center, Duarte, CA, US.
  • Gaal KK; Department of Pathology City of Hope National Medical Center, Duarte, CA, US.
  • Kim Y; Department of Pathology City of Hope National Medical Center, Duarte, CA, US.
Am J Clin Pathol ; 161(2): 170-176, 2024 Feb 01.
Article em En | MEDLINE | ID: mdl-37904278
ABSTRACT

OBJECTIVES:

Determination of bone marrow cellularity is a key part of bone marrow examination because it provides a small window into a patient's current state of hematopoietic well-being. Traditionally, bone marrow cellularity is estimated semiquantitatively through microscopic examination of core biopsy specimens harvested from the iliac crest of the pelvic bone. Bone marrow cellularity is then designated as hypercellular, normocellular, or hypocellular based on the patient's age. This assessment can have significant clinical impact, but the variation in the age-adjusted normocellularity range is not sufficiently characterized because of a lack of study data, especially in older patients (those older than 70 years of age). This study further established the normal range of bone marrow cellularity, particularly in older adults.

METHODS:

In this study, 570 benign staging and healthy donor bone marrows from patients 1 year to 93 years of age were analyzed for cellularity.

RESULTS:

Linear regression modeling demonstrates that cellularity in adults declines approximately 3% per decade, including after the seventh decade of life. The 90% reference interval for normocellularity in United States is 30% to 75% for those aged 18 to 90 years.

CONCLUSIONS:

The findings revealed a more stable and slower rate of decline in cellularity with age in adults than the widely used linear model of "100% minus the patient age in decades." Normocellularity is better modeled based on age group. In those younger than 20 years of age, normocellularity ranges from 45% to 85% (mean [SD], 65% [20%]), as defined by Friebert et al in 1998. Based on our study finding of a little less than 3% decline per decade of age, the following is our recommendation for normocellularity range For individuals 20 to 40 years of age, it ranges from 40% to 70% (mean [SD], 55% [15%]); for individuals 40 to 60 years of age, it ranges from 35% to 65% (mean [SD], 50% [15%]); and for individuals older than 60 years of age, it ranges from 30% to 60% (mean [SD], 45% [15%]). Interestingly, those older than 70 years of age do not show a significant decrease from those aged 60 to 69 years.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Medula Óssea / Células da Medula Óssea Limite: Adult / Aged / Humans / Infant Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Medula Óssea / Células da Medula Óssea Limite: Adult / Aged / Humans / Infant Idioma: En Ano de publicação: 2024 Tipo de documento: Article